Two-year efficacy and safety in abatacept-treated patients with RA who received continuous therapy or switched from infliximab to abatacept: the ATTEST trial

Authors
Category Primary study
JournalAnn Rheum Dis
Year 2009

This article is included in 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • ATTEST [Abatacept or infliximab vs placebo, a Trial for Tolerability, Efficacy and Safety in Treating rheumatoid arthritis] (7 documents)
Loading references information
This article has no abstract
Epistemonikos ID: f3ca80067069b1b13fff0e951ba678b258a71c1c
First added on: Nov 01, 2017